Aakaar Medical Technologies was incorporated on June 20, 2013. The company operates in the medical aesthetics space, offering both own and imported brands from countries like Korea, Spain, and Italy. It distributes products B2B to dermatologists and aesthetic doctors, with a strong focus on its aesthetics product pipeline
| Bidding Dates |
|---|
| 20 Jun 2025 - 24 Jun 2025 |
| Subscription |
|---|
| 2.19x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,08,800 | 1 | 1 | 1600 | 3.8 M | ₹68 - ₹72 | 67.01 % | ₹255.0 M - ₹270.0 M | RHP DOC |
Aakaar Medical Technologies IPO SUBSCRIPTION STATUS
24 Jun '25Aakaar Medical Technologies IPO overall subscription rate was 2.19 times the total available shares
Aakaar Medical Technologies IPO retail subscription rate was 2.57 times in the retail segment
Aakaar Medical Technologies IPO non-institutional investor subscription rate was 2.44 times in the non-institutional investor category
Aakaar Medical Technologies IPO Qualified Institutional Bidder subscription rate was 1.86 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
24 Jun 2025 (Day 3) | 2.57x | 2.44x | 1.86x |
23 Jun 2025 (Day 2) | 1.15x | 1.34x | 0.18x |
20 Jun 2025 (Day 1) | 0.39x | 0.78x | 0.18x |
Aakaar Medical Technologies FINANCIALS
| Period | Net Profit (Rs in crore) | Revenue from Operations (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 6.0 | 61.6 | -5.4 | -5.5 | 15.8% |
| FY24 | 2.9 | 46.1 | -8.0 | -8.1 | 10.8% |
| FY23 | 2.2 | 32.8 | -2.9 | -3.2 | 10.8% |
Aakaar Medical Technologies IPO SUBSCRIPTION STATUS DETAILS
Aakaar Medical Technologies had 3.8 M shares on offer
Aakaar Medical Technologies IPO offer price was in the range ₹68 - ₹72
Aakaar Medical Technologies IPO minimum Investment was ₹108800
Aakaar Medical Technologies IPO issue size was ₹ 255.0 M - ₹ 270.0 M
Aakaar Medical Technologies had a minimum lot size of 1600 Shares per application
Aakaar Medical Technologies NUMBER OF SHARES ON OFFER
Aakaar Medical Technologies IPO IMPORTANT DATES
| Issue Open Date | 20 Jun 2025 |
| Issue close Date | 24 Jun 2025 |
| Allotment Date | 25 Jun 2025 |
| Refund Date | 26 Jun 2025 |
| Demat Account Credit Date | 26 Jun 2025 |
| Listing Date | 27 Jun 2025 |
| Listing on Exchange(s) | NSE |
| Aakaar Medical Technologies Allotment Status | Exchange/ Registrar |
Aakaar Medical Technologies IPO subscription opened on 20 Jun 2025, and closed on 24 Jun 2025
IPO allotment for Aakaar Medical Technologies was finalized on Wednesday, 25 Jun 2025
IPO listing for Aakaar Medical Technologies was on NSE on Friday, 27 Jun 2025
Aakaar Medical Technologies IPO LISTING GAINS
| Issue Price (adjusted) | 72.0 |
| Listing Open Price | 75.0 |
| Listing Close Price | 71.3 |
| Listing Gain% | 4.2% |
| Current Gain% | -16.0% |
Aakaar Medical Technologies Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aakaar Medical Technologies Ltd. | 60.5 | 85.7 | 12.9 | 1.3 | 1.3 | 12.2 | 8.4 | 67.8 | 9.7 | 6.6 | 9.9 | 4.7 | 9.9 |
| Tarsons Products Ltd. | 312.3 | 1661.6 | 116 | -2.2 | 3.9 | 2.2 | 1.2 | 446.7 | 9.4 | 14.3 | -51.9 | 2.7 | -51.9 |
| Fabtech Technologies Cleanrooms Ltd. | 385 | 474.3 | 30 | 15.2 | 8.5 | 221.7 | 46.9 | 15.8 | 19 | 12.8 | |||
| Hemant Surgical Industries Ltd. | 356.2 | 464.5 | 24.2 | 13.9 | 7 | 237.7 | 112.7 | 19.2 | 138.7 | 14.7 | |||
| Prevest Denpro Ltd. | 380.8 | 457.1 | 22.3 | 1.7 | 6.4 | 16.4 | 15.4 | 76.7 | 14.4 | 20.5 | 12.9 | 17.1 | 12.9 |
| Aprameya Engineering Ltd. | 142.6 | 271.5 | 53.2 | 7.4 | 6.2 | 55.6 | -59.2 | 5.1 | -68.3 | 2.7 |
Aakaar Medical Technologies INFORMATION ON IPO ISSUE
About Aakaar Medical Technologies
Aakaar Medical Technologies was incorporated on June 20, 2013. The company operates in the medical aesthetics space, offering both own and imported brands from countries like Korea, Spain, and Italy. It distributes products B2B to dermatologists and aesthetic doctors, with a strong focus on its aesthetics product pipeline
Object of the Issue
- Funding working capital requirements of the company
- General corporate purposes
Aakaar Medical Technologies - PROMOTERS
| Name |
|---|
| Dilip Ramesh Meswani |
| Bindi Dilip Mesawni |
Aakaar Medical Technologies Book Running Lead Manager
Indorient Financial Services Limited
compliance-ifsl@indorient.in
Aakaar Medical Technologies Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Aakaar Medical Technologies Strengths
Diverse product portfolio
The company offers a wide product portfolio with 154 SKUs and over 5.4 lakh units sold in FY25, making it a one-stop solution for dermatologists across home care, professional care, injectables, contouring, and devices
Enhance delivery & revenue
The company has partnered with Parekh Integrated Services Pvt. Ltd. (PISPL) as its CSA partner, leveraging 21 warehouses nationwide to ensure faster product delivery and wider reach. This partnership is expected to drive the majority of future revenue
Diverse customer base
The company serves over 5,200 doctors and clinic chains across India, with a dynamic customer base that changes annually. In FY24, its top 10 customers contributed 10.96% of total revenue
Aakaar Medical Technologies Risks
Depend on third party manufacturers
The company relies on third-party and loan licensing manufacturers for its branded products. Disruptions in supply, quality, or financial stability of these partners may impact its operations, cash flows, and financial condition
Capital intensive
The company’s growth depends on sufficient working capital to fund inventory and customer credit. Any shortfall in meeting these needs may adversely impact its operations and financial results
Operational risks
The company has appointed Parekh Integrated Services Pvt. Ltd. (PISPL) as its CSA agent for storage, delivery, distribution, and recovery. Any non-performance or breach by PISPL may negatively impact the company’s operations, profitability, and cash flows
IPO FAQs
The promoters of the company are Dilip Ramesh Meswani and Bindi Dilip Mesawni.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 68.0 - 72.0.
The IPO application opens on Jun 20, 2025 and closes on Jun 24, 2025.
The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.
For all category investors, the minimum application amount for this IPO is Rs. 108,800.0, the maximum value for this IPO is Rs 115,200.0.
This IPO will be allotted on Jun 25, 2025.
The refund will be credited to your account on Jun 26, 2025.
The allotted shares will be credited to your demat on Jun 26, 2025.
Aakaar Medical Technologies Ltd.’s shares listed on the stock exchanges on Jun 27, 2025.